Ironwood Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Ironwood Pharmaceuticals

15/02/2024 14:33

* Ironwood Pharmaceuticals Inc  IRWD.OQ  reported a
quarterly
adjusted loss of 1 cent​​ per share for the quarter ended in
December, lower than the same quarter last year, when the
company reported EPS of 27 cents.  The mean expectation of
six analysts for the quarter was for earnings of 21 cents per
share. Wall Street expected results to range from 13 cents to 39
cents per share.
    * Revenue rose 9.7% to $117.55 million from a year ago;
analysts
expected $117.48 million. 
    * Ironwood Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 1 cent​.
    * The company reported a quarterly loss of $1.75 million.
    * Ironwood Pharmaceuticals Inc shares had risen by 35.1%
this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Ironwood
Pharmaceuticals Inc is $20.50 

This summary was machine generated from LSEG data February 15 at
02:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      0.21           -0.01          Missed
 Sep. 30 2023      0.16           0.09           Missed
 Jun. 30 2023      0.25           0.31           Beat
 Mar. 31 2023      0.24           0.25           Beat